Use of extracellular vesicle microRNA profiles in patients with acute myeloid leukemia for the identification of novel biomarkers
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0306962 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Ka-Won Kang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Hematology-Oncology, Korea University College of Medicine, Seoul, South Korea. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, MicroRNAs, Extracellular Vesicles, Biomarkers, Tumor. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Seoul Business Agency, Korea University, National Research Foundation of Korea (NRF) grant funded by the Korean Government.
Abstract (Originalsprache)
Objectives
This study aimed to establish clinically significant microRNA (miRNA) sets using extracellular vesicles (EVs) from bone marrow (BM) aspirates of patients with acute myelogenous leukemia (AML), and to identify the genes that interact with these EV-derived miRNAs in AML. Materials and methods BM aspirates were collected from 32 patients with AML at the time of AML diagnosis. EVs were isolated using size-exclusion chromatography. A total of 965 EV-derived miRNAs were identified in all the samples.
Results
We analyzed the expression levels of these EV-derived miRNAs of the favorable (n = 10) and non-favorable (n = 22) risk groups; we identified 32 differentially expressed EV-derived miRNAs in the non-favorable risk group. The correlation of these miRNAs with risk stratification and patient survival was analyzed using the information of patients with AML from The Cancer Genome Atlas (TCGA) database. Of the miRNAs with downregulated expression in the non-favorable risk group, hsa-miR-181b and hsa-miR-143 were correlated with non-favorable risk and short overall survival. Regarding the miRNAs with upregulated expression in the non-favorable risk group, hsa-miR-188 and hsa-miR-501 were correlated with non-favorable risk and could predict poor survival. Through EV-derived miRNAs–mRNA network analysis using TCGA database, we identified 21 mRNAs that could be potential poor prognosis biomarkers.
Conclusions
Overall, our findings revealed that EV-derived miRNAs can serve as biomarkers for risk stratification and prognosis in AML. In addition, these EV-derived miRNA-based bioinformatic analyses could help efficiently identify mRNAs with biomarker potential, similar to the previous cell-based approach.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Division of Hematology-Oncology, Korea University College of Medicine, Seoul, South Korea.
- Department of Medical Science, Soonchunhyang University, Asan-si, South Korea.
- School of Biosystem and Biomedical Science, Korea University, Seoul, South Korea.
- Department of Thoracic and Cardiovascular Surgery, Korea University College of Medicine, Seoul, South Korea.
- Department of Bio-convergence Engineering, Korea University, Seoul, South Korea.
- Department of Bio and Brain Bioengineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, South Korea.
ORCID-Profile: Ka-Won Kang, Jeong-An Gim, Yong Park
Förderung
- Seoul Business Agency
- Korea University
- National Research Foundation of Korea (NRF) grant funded by the Korean Government
Zitieren
APA
Kang, K. W., Gim, J. A., Hong, S., Kim, H. K., Choi, Y., Park, J. H., & Park, Y. (2024). Use of extracellular vesicle microRNA profiles in patients with acute myeloid leukemia for the identification of novel biomarkers. PLOS ONE. https://doi.org/10.1371/journal.pone.0306962
Vancouver
Kang KW, Gim JA, Hong S, Kim HK, Choi Y, Park JH, et al. Use of extracellular vesicle microRNA profiles in patients with acute myeloid leukemia for the identification of novel biomarkers. PLOS ONE. 2024. doi:10.1371/journal.pone.0306962
BibTeX
@article{Kang2024,
author = {Kang, Ka-Won and Gim, Jeong-An and Hong, Sunghoi and Kim, Hyun Koo and Choi, Yeonho and Park, Ji-Ho and Park, Yong},
title = {Use of extracellular vesicle microRNA profiles in patients with acute myeloid leukemia for the identification of novel biomarkers},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0306962}
}
EUVIMED